Bio Business

» biobusiness

Most Recent

image: Bringing the Internet of Things into the Lab

Bringing the Internet of Things into the Lab

By Abby Olena | June 1, 2018

The IoT can link up many facets of research—from laboratory equipment to ideas—but scientists must be ready for the questions its implementation could raise.

1 Comment

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

image: Accessing Drugs for Medical Aid-in-Dying

Accessing Drugs for Medical Aid-in-Dying

By Catherine Offord | August 17, 2017

A fraught market for the barbiturates prescribed to terminally ill patients who choose to end their lives has physicians turning to options outside big pharma.

0 Comments

image: Learning from Iceland’s Model for Genetic Research

Learning from Iceland’s Model for Genetic Research

By Catherine Offord | June 1, 2017

The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.

1 Comment

image: The Growth of Iowa Biotech

The Growth of Iowa Biotech

By Jenny Rood | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

1 Comment

image: Cannabis Biotech

Cannabis Biotech

By Daniel Cossins | December 1, 2014

As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.

2 Comments

image: Incubator Boom

Incubator Boom

By Kerry Grens | March 1, 2014

From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?  

2 Comments

image: Treating Fat with Fat

Treating Fat with Fat

By Edyta Zielinska | May 1, 2012

Is brown fat ready for therapeutic prime time?

22 Comments

image: Braving the IPO Drought

Braving the IPO Drought

By Megan Scudellari | March 1, 2012

Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.

0 Comments

image: Take Two of These

Take Two of These

By Bob Grant | June 22, 2011

Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.

3 Comments

Popular Now

  1. Dartmouth Professor Investigated for Sexual Misconduct Retires
  2. Two University of Rochester Professors Resign in Protest
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Laxative Causes Long-Term Changes to Mouse Microbiome